课题基金 / 基金详情

NEUROIMAGING AND NEURODEVELOPMENTAL OUTCOME: A SECONDARY TO SURFACTANT

NEUROIMAGING AND NEURODEVELOPMENTAL OUTCOME: A SECONDARY TO SURFACTANT
神经成像和神经发育结果:表面活性剂的次要药物
批准号:
8166608
负责人:
KRISTI L. WATTERBERG
金额:
$0.09万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-12-01 至 2010-06-30

项目摘要

项目成果

KRISTI L. WATTERBERG的其他基金

相似基金

相关文献

中文摘要
翻译
这个子项目是众多研究子项目之一
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. This study looks at two different testing procedures, ultrasounds and brain magnetic resonance imaging [MRI], to see if one test is better at predicting neurological outcome in extremely premature babies. This study will gather information on imaging studies and use it together with data collected in the SUPPORT Trial to learn more about medical problems of premature infants such as brain injury, and neurological and developmental outcome.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Adrenal function and adverse CV outcomes at age 6 after extremely preterm birth
Adrenal function and adverse CV outcomes at age 6 after extremely preterm birth
Adrenal function and adverse CV outcomes at age 6 after extremely preterm birth
THE SURFACTANT POSITIVE AIRWAY PRESSURE AND PULSE OXIMETRY TRIAL
  • 批准号:
    8166603
  • 项目类别:
  • 资助金额:
    $3.54万
  • 财政年份:
    2009
  • 负责人:
    KRISTI L. WATTERBERG
  • 依托单位:
海外基金